期刊文献+

兔抗MAGEn血清的制备、纯化及鉴定 被引量:2

下载PDF
导出
摘要  目的: 制备高效价、特异性的兔抗人MAGE-n血清。方法: 对原核表达的MAGE-n蛋白进行纯化, 与弗氏佐剂混合免疫新西兰兔制备抗血清, 用硫酸铵盐析法及溴化氰活化的Sephrose4B(CNBr-ActivatedSephrose4B)亲和层析柱纯化抗血清, 以双向免疫扩散实验、ELISA、Westernblot和免疫组化对兔抗人MAGE-n血清进行鉴定。结果: 经免疫得到高效价的兔抗人MAGE-n血清, 抗血清能够与MAGE-n特异性结合, 免疫组化结果表明MAGE-n是一种胞质蛋白。结论: 用MAGE-n蛋白与弗氏佐剂混合免疫兔, 制备得到高效价的抗血清, 纯化后的特异性兔抗人MAGE-n血清, 为进一步研究MAGE-n在各种组织中的表达奠定了基础。
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2005年第2期196-197,共2页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目 (No. 30271464 ) 全军医药卫生科研基金重点资助项目(No. 01Z084)
  • 相关文献

参考文献4

二级参考文献34

  • 1[1]van der Bruggen P,Traversari C,Chomez P,et al.A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma[J].Science,1991,254(5038):1643-1647.
  • 2[2]Gaugler B,Olive D.Tumor antigens recognized by T-lymphocytes in human cancers.New advances and therapeutic perspectives[J].Pathol Biol (Paris),1998,46(10):771-778.
  • 3[3]Tahara K,Mori M,Sadanaga N,et al.Expression of the MAGE gene family in human hepatocellular carcinoma[J].Cancer,1999,85(6):1234-1240.
  • 4[4]Tartaglia J,Bonnet MC,Berinstein N,et al.Therapeutic vaccines against melanoma and colorectal cancer[J].Vaccine,2001,19(17-19):2571-2575.
  • 5[5]Forslund K,Nordqvist K.The melanoma antigen genes-any clues to their functions in normal tissues[J].Exp Cell Res,2001,265(2):185-194.
  • 6[6]Sadanaga N,Nagashima H,Mashino K,et al.Dendritic cell vaccination with mage peptide is a novel therapeutic approach for gastrointestinal carcinomas[J].Clin Cancer Res,2001,7(8):2277-2284.
  • 7[7]Dutoit V,Rubio-Godoy V,Dietrich PY,et al.Heterogeneous T-cell response to MAGE-A10(254-262):high avidity-specific cytolytic T lymphocytes show superior antitumor activity[J].Cancer Res,2001,61(15):5850-5856.
  • 8[8]Griffioen M,Borghi M,Schrier PI,et al.Detection and quantification of CD8+T cells specific for HLA-A*0201-binding melanoma and viral peptides by the IFN-gamma-ELISPOT assay[J].Int J Cancer,2001,93(4):549-555.
  • 9[9]Beck A,Bussat MC,Klinguer-Hamour C,et al.Stability and CTL activity of N-terminal glutamic acid containing peptides[J].J Pept Res,2001,57(6):528-538.
  • 10[10]Chaux P,Lethe B,Van Snick J,et al.A MAGE-1 peptide recognized on HLA-DR15 by CD4+T cells[J].Eur J Immunol,2001,31(6):1910-1916.

共引文献21

同被引文献26

  • 1周红,何小珍,段志贵,晏小军,胡绍海,王贤纯,梁宋平.间斑寇蛛(L.tredecimguttatus)室内饲养及活体采毒方法的初步探讨[J].蛛形学报,2005,14(1):58-63. 被引量:12
  • 2肖洁,郭刚,邹全明.提高大肠杆菌分泌表达重组蛋白的研究进展[J].微生物学杂志,2007,27(2):73-77. 被引量:9
  • 3宋彬,熊鸿燕.肠出血性大肠杆菌O157的流行病学研究进展[J].山西医科大学学报,2007,38(8):760-764. 被引量:12
  • 4Bonnet MS.2004.The toxicology of Latrodectus tredecimguttatus:the Mediterranean Black Widow spider.Homeopathy,3(1):27-33
  • 5Bradford MM.1976.A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem,72:248-254
  • 6Calista D,Venturelli C,Morri M.2004.Latrodectus tredecimguttatus spider bite.British Journal of Dermatology,151:505-505
  • 7Dzelalija B,Medic A.2003.Latrodectus bites in northern Dalmatia,Croatia:clinical,laboratory,epidemiological,and therapeutical aspects.Croat Med J,44(2):135-138
  • 8Graudins A,Padula M,Broady K,et al.2001.Red-back spider(Latrodectus hasselti) antivenom prevents the toxicity of widow spider venoms.Ann Emerg Med,37(2):154-160
  • 9Graudins A,Gunja N,Broady KW,et al.2002.Clinical and in vitro evidence for the efficacy of Australian red-back spider (Latrodectus hasselti) antivenom in the treatment of envenomation by a Cupboard spider (Steatoda grossa).Toxicon,40(6):767-775
  • 10Jones RG,Corteling RL,Bhogal G,et al.1999.A novel Fab-based antivenom for the treatment of mass bee attacks.Am J Trop Med Hyg,61(3):361-366

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部